The PRIMATE CENTER CORE Group, at the California Primate Center (CPRC), will provide support to the project where nonhuman primates are used. This includes all aspects of research done on primates, supplying animals, animal housing (both indoor and outdoor), veterinary care, special handling of animals, centralized facilities for clinical laboratory work, computer support and administration. All efforts will be incorporated into the existing administrative structure which has been established to ensure compliance with all University, State, and Federal regulations dealing with animal care. Two disease models of acquired retroviral immunosuppression in macaques are under study at the Primate Center: (1) simian type D retrovirus (SRV-1, MPMV, SRV-2) and (2) simian immunodeficiency virus (SIV). Research in both models is supported by grants from NIH, the state of California, and private foundations. Emphasis is on mechanisms of pathogenesis and development of antiviral therapies and vaccines. The SIV model is probably the most directly applicable to human AIDS and serves as an excellent link between basic laboratory investigations and potential clinical application of pharmacologic and immunization procedures. Importantly, HIV-2 can establish a persistent infection in rhesus monkeys and, thus, may be a useful system for investigating many aspects of infection of humans by immunodeficiency lentiviruses. Many of these research investigations will require direct interactions of the MOLECULAR VIROLOGY and CLINICAL VIROLOGY CORE components in this CFAR. The model systems involving rhesus monkeys provide an immensely valuable resource which is yet underutilized and will gladly be shared with other investigators in academia, government, and industry. Full utilization of the expertise of many researchers at U.C. Davis will be greatly facilited by the animal and laboratory units, renovations, equipment, and other resources requested in this application for a Center for AIDS Research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
1P30AI027732-01
Application #
3818947
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Yamanaka, M K; Yilma, T (1998) Altered plaque formation by recombinant vaccinia virus expressing simian immunodeficiency virus Nef. J Virol 72:5291-5
Giavedoni, L D; Yilma, T (1996) Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon. J Virol 70:2247-51
Gardner, M; Rosenthal, A; Jennings, M et al. (1995) Passive immunization of rhesus macaques against SIV infection and disease. AIDS Res Hum Retroviruses 11:843-54
Luciw, P A; Pratt-Lowe, E; Shaw, K E et al. (1995) Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc Natl Acad Sci U S A 92:7490-4
Gardner, M B; Rosenthal, A; Jennings, M et al. (1994) Passive immunization of macaques against SIV infection. J Med Primatol 23:164-74
Ahmad, S; Lohman, B; Marthas, M et al. (1994) Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res Hum Retroviruses 10:195-204
Herchenroder, O; Renne, R; Loncar, D et al. (1994) Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology 201:187-99
Anderson, D E; Malley, A; Benjamini, E et al. (1994) Hypervariable epitope constructs as a means of accounting for epitope variability. Vaccine 12:736-40
Torres, J V; Malley, A; Banapour, B et al. (1993) An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation. AIDS Res Hum Retroviruses 9:423-30
Yamamoto, J K; Hohdatsu, T; Olmsted, R A et al. (1993) Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J Virol 67:601-5

Showing the most recent 10 out of 25 publications